0
     

Report Added
Report already added
Gene Therapy Market - Global Outlook and Forecast 2021-2027

Gene Therapy Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of Gene Therapy in Global, including the following market information:
Global Gene Therapy Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Gene Therapy market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Gene Therapy Market Segment Percentages, By Type, 2020 (%)
Ex vivo
In Vivo

China Gene Therapy Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Gene Therapy Market Segment Percentages, By Application, 2020 (%)
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other

Global Gene Therapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Gene Therapy Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Gene Therapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Gene Therapy Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
1 Introduction to Research & Analysis Reports
1.1 Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy Overall Market Size
2.1 Global Gene Therapy Market Size: 2021 VS 2027
2.2 Global Gene Therapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapy Players in Global Market
3.2 Top Global Gene Therapy Companies Ranked by Revenue
3.3 Global Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Therapy Market Size Markets, 2021 & 2027
4.1.2 Ex vivo
4.1.3 In Vivo
4.2 By Type - Global Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Gene Therapy Revenue, 2016-2021
4.2.2 By Type - Global Gene Therapy Revenue, 2022-2027
4.2.3 By Type - Global Gene Therapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapy Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Monogenic
5.1.4 Infectious Disease
5.1.5 Cardiovascular Disease
5.1.6 Other
5.2 By Application - Global Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Gene Therapy Revenue, 2016-2021
5.2.2 By Application - Global Gene Therapy Revenue, 2022-2027
5.2.3 By Application - Global Gene Therapy Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Gene Therapy Market Size, 2021 & 2027
6.2 By Region - Global Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Gene Therapy Revenue, 2016-2021
6.2.2 By Region - Global Gene Therapy Revenue, 2022-2027
6.2.3 By Region - Global Gene Therapy Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Gene Therapy Revenue, 2016-2027
6.3.2 US Gene Therapy Market Size, 2016-2027
6.3.3 Canada Gene Therapy Market Size, 2016-2027
6.3.4 Mexico Gene Therapy Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Gene Therapy Revenue, 2016-2027
6.4.2 Germany Gene Therapy Market Size, 2016-2027
6.4.3 France Gene Therapy Market Size, 2016-2027
6.4.4 U.K. Gene Therapy Market Size, 2016-2027
6.4.5 Italy Gene Therapy Market Size, 2016-2027
6.4.6 Russia Gene Therapy Market Size, 2016-2027
6.4.7 Nordic Countries Gene Therapy Market Size, 2016-2027
6.4.8 Benelux Gene Therapy Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Gene Therapy Revenue, 2016-2027
6.5.2 China Gene Therapy Market Size, 2016-2027
6.5.3 Japan Gene Therapy Market Size, 2016-2027
6.5.4 South Korea Gene Therapy Market Size, 2016-2027
6.5.5 Southeast Asia Gene Therapy Market Size, 2016-2027
6.5.6 India Gene Therapy Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Gene Therapy Revenue, 2016-2027
6.6.2 Brazil Gene Therapy Market Size, 2016-2027
6.6.3 Argentina Gene Therapy Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapy Revenue, 2016-2027
6.7.2 Turkey Gene Therapy Market Size, 2016-2027
6.7.3 Israel Gene Therapy Market Size, 2016-2027
6.7.4 Saudi Arabia Gene Therapy Market Size, 2016-2027
6.7.5 UAE Gene Therapy Market Size, 2016-2027
7 Players Profiles
7.1 Bluebird Bio
7.1.1 Bluebird Bio Corporate Summary
7.1.2 Bluebird Bio Business Overview
7.1.3 Bluebird Bio Gene Therapy Major Product Offerings
7.1.4 Bluebird Bio Gene Therapy Revenue in Global (2016-2021)
7.1.5 Bluebird Bio Key News
7.2 Sangamo
7.2.1 Sangamo Corporate Summary
7.2.2 Sangamo Business Overview
7.2.3 Sangamo Gene Therapy Major Product Offerings
7.2.4 Sangamo Gene Therapy Revenue in Global (2016-2021)
7.2.5 Sangamo Key News
7.3 Spark Therapeutics
7.3.1 Spark Therapeutics Corporate Summary
7.3.2 Spark Therapeutics Business Overview
7.3.3 Spark Therapeutics Gene Therapy Major Product Offerings
7.3.4 Spark Therapeutics Gene Therapy Revenue in Global (2016-2021)
7.3.5 Spark Therapeutics Key News
7.4 Dimension Therapeutics
7.4.1 Dimension Therapeutics Corporate Summary
7.4.2 Dimension Therapeutics Business Overview
7.4.3 Dimension Therapeutics Gene Therapy Major Product Offerings
7.4.4 Dimension Therapeutics Gene Therapy Revenue in Global (2016-2021)
7.4.5 Dimension Therapeutics Key News
7.5 Avalanche Bio
7.5.1 Avalanche Bio Corporate Summary
7.5.2 Avalanche Bio Business Overview
7.5.3 Avalanche Bio Gene Therapy Major Product Offerings
7.5.4 Avalanche Bio Gene Therapy Revenue in Global (2016-2021)
7.5.5 Avalanche Bio Key News
7.6 Celladon
7.6.1 Celladon Corporate Summary
7.6.2 Celladon Business Overview
7.6.3 Celladon Gene Therapy Major Product Offerings
7.6.4 Celladon Gene Therapy Revenue in Global (2016-2021)
7.6.5 Celladon Key News
7.7 Vical Inc.
7.7.1 Vical Inc. Corporate Summary
7.7.2 Vical Inc. Business Overview
7.7.3 Vical Inc. Gene Therapy Major Product Offerings
7.4.4 Vical Inc. Gene Therapy Revenue in Global (2016-2021)
7.7.5 Vical Inc. Key News
7.8 Advantagene
7.8.1 Advantagene Corporate Summary
7.8.2 Advantagene Business Overview
7.8.3 Advantagene Gene Therapy Major Product Offerings
7.8.4 Advantagene Gene Therapy Revenue in Global (2016-2021)
7.8.5 Advantagene Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Gene Therapy Market Opportunities & Trends in Global Market
Table 2. Gene Therapy Market Drivers in Global Market
Table 3. Gene Therapy Market Restraints in Global Market
Table 4. Key Players of Gene Therapy in Global Market
Table 5. Top Gene Therapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Gene Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Gene Therapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Gene Therapy Product Type
Table 9. List of Global Tier 1 Gene Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Gene Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Gene Therapy Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Gene Therapy Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Gene Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Gene Therapy Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Gene Therapy Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Gene Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Gene Therapy Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Gene Therapy Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Gene Therapy Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Gene Therapy Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Gene Therapy Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Gene Therapy Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Gene Therapy Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Gene Therapy Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Gene Therapy Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Gene Therapy Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Gene Therapy Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Gene Therapy Revenue, (US$, Mn), 2022-2027
Table 30. Bluebird Bio Corporate Summary
Table 31. Bluebird Bio Gene Therapy Product Offerings
Table 32. Bluebird Bio Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 33. Sangamo Corporate Summary
Table 34. Sangamo Gene Therapy Product Offerings
Table 35. Sangamo Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 36. Spark Therapeutics Corporate Summary
Table 37. Spark Therapeutics Gene Therapy Product Offerings
Table 38. Spark Therapeutics Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 39. Dimension Therapeutics Corporate Summary
Table 40. Dimension Therapeutics Gene Therapy Product Offerings
Table 41. Dimension Therapeutics Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 42. Avalanche Bio Corporate Summary
Table 43. Avalanche Bio Gene Therapy Product Offerings
Table 44. Avalanche Bio Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 45. Celladon Corporate Summary
Table 46. Celladon Gene Therapy Product Offerings
Table 47. Celladon Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 48. Vical Inc. Corporate Summary
Table 49. Vical Inc. Gene Therapy Product Offerings
Table 50. Vical Inc. Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 51. Advantagene Corporate Summary
Table 52. Advantagene Gene Therapy Product Offerings
Table 53. Advantagene Gene Therapy Revenue (US$, Mn), (2016-2021)

List of Figures
Figure 1. Gene Therapy Segment by Type
Figure 2. Gene Therapy Segment by Application
Figure 3. Global Gene Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Gene Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Gene Therapy Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy Revenue in 2020
Figure 8. By Type - Global Gene Therapy Revenue Market Share, 2016-2027
Figure 9. By Application - Global Gene Therapy Revenue Market Share, 2016-2027
Figure 10. By Region - Global Gene Therapy Revenue Market Share, 2016-2027
Figure 11. By Country - North America Gene Therapy Revenue Market Share, 2016-2027
Figure 12. US Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Gene Therapy Revenue Market Share, 2016-2027
Figure 16. Germany Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 17. France Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Gene Therapy Revenue Market Share, 2016-2027
Figure 24. China Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 28. India Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Gene Therapy Revenue Market Share, 2016-2027
Figure 30. Brazil Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Gene Therapy Revenue Market Share, 2016-2027
Figure 33. Turkey Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 37. Bluebird Bio Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Sangamo Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Spark Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Dimension Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Avalanche Bio Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Celladon Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Vical Inc. Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Report Title: Gene Therapy Market - Global Outlook and Forecast 2021-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2021-2025 Vietnam Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Vietnam Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Venezuela Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Venezuela Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Uruguay Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Uruguay Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 United Arab Emirates Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 United Arab Emirates Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Ukraine Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Ukraine Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Turkey Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Turkey Transfusion Diagnostics Market Opportunities, Shares and Forecasts-Immunohematology and Infectious Disease Screening Analyzers and Reagents-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers